Price basis
Starting offer, not a confirmed monthly charge
Quantity
Confirm bottle volume and strength
Renewal
Request the selected plan terms

What this review covers

Wisp NAD+ Nasal Spray is a prescription product advertised within the company's longevity range. This review concerns the spray itself: its purchase options, what the public price does and does not cover, and the questions needed to identify the dispensed formulation. Wisp's broader company services are discussed in the linked provider profile.

The nasal format may appeal to someone who wants to avoid needles. That convenience does not establish equal absorption, equivalent clinical results or a particular safety advantage compared with an injection or an IV visit. A route of administration is one element of a prescription, rather than a substitute for evaluating the finished product.

Reading the $150 offer

The public page displays a starting price of $150 and mentions both one-time treatment and subscription choices. We could not establish a single package size and renewal schedule tied to that headline. Our catalog therefore treats the amount as a starting offer, with no verified monthly equivalent or annual total.

Free delivery is advertised, which removes one possible ambiguity from the headline. Other amounts still need to be confirmed: any consultation fee, the actual quantity supplied and what the next prescription costs. If the subscription is less expensive than buying once, evaluate its cancellation terms alongside the discount rather than assuming the lower price has no commitment.

Details to obtain for the actual bottle

Ask for the labeled concentration, container volume and total NAD+ content. These describe different things and should not be used interchangeably. A page that simply says nasal spray cannot tell you whether two providers supply comparable quantities, and a photo of a bottle is not a reliable measurement.

The dispensing pharmacist should also explain storage, the beyond-use date and what to do if the package arrives damaged or appears inconsistent with the label. Use the clinician's and pharmacy's instructions for the prescribed product. Our price listing is not a dosing guide or a basis for adjusting how often a spray is used.

Energy and focus claims need product evidence

Wisp connects the product with cellular energy, cognition and healthy aging, and uses language suggesting prompt effects. These are provider claims. We have not verified a controlled study showing a predictable improvement in those outcomes with this particular spray, so the review does not present a time-to-results promise.

NAD+ is a coenzyme involved in metabolism; it is not a peptide despite appearing alongside peptide services in many catalogs. Research on intravenous NAD+ or oral precursors cannot automatically be applied to this intranasal preparation. The route, formulation, patient population and measured outcome all matter when judging a claim.

A practical decision checklist

Before ordering, confirm that the provider can evaluate you in your location and identify who will handle clinical follow-up. Ask whether the prescription is compounded; compounded drugs are not FDA-approved. If persistent low energy or new cognitive symptoms prompted the search, discuss their evaluation rather than assuming a wellness product addresses the underlying cause.

The published starting price and delivery statement make Wisp useful to investigate, but the missing quantity and renewal details prevent a precise value comparison today. A complete written quote and pharmacy information are the next useful evidence. Neither a company testimonial nor a low headline amount can fill those gaps for an individual prescription.

Useful distinctions

  • Non-injectable format
  • Delivery included in advertised offer
  • Separate one-time and subscription choices

Limitations to weigh

  • No verified bottle strength or supply duration
  • No reliable per-month comparison from starting price
  • Rapid-benefit claims not independently established

Sources & further reading

Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.

  1. Wisp: NAD+ Nasal Spray and advertised starting price Provider
  2. FDA: Compounding questions and answers Regulator
  3. PubChem: Nicotinamide adenine dinucleotide Chemical reference